PHENINDAMINE TARTRATE

US Approved OTC

First approved in 1947

Details

Stereochemistry	EPIMERIC
Molecular Formula	C19H19N.C4H6O6
Molecular Weight	411.4477
Optical Activity	UNSPECIFIED
Defined Stereocenters	2 / 3
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

O[C@H]([C@@H](O)C(O)=O)C(O)=O.CN1CCC2=C(C1)C(C3=CC=CC=C23)C4=CC=CC=C4

InChI

InChIKey=WFXURHIXPXVPGM-LREBCSMRSA-N

InChI=1S/C19H19N.C4H6O6/c1-20-12-11-16-15-9-5-6-10-17(15)19(18(16)13-20)14-7-3-2-4-8-14;5-1(3(7)8)2(6)4(9)10/h2-10,19H,11-13H2,1H3;1-2,5-6H,(H,7,8)(H,9,10)/t;1-,2-/m.1/s1

HIDE SMILES / InChI

Molecular Formula	C4H6O6
Molecular Weight	150.0868
Charge	0
Count

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	2 / 2
E/Z Centers	0
Optical Activity	UNSPECIFIED

Molecular Formula	C19H19N
Molecular Weight	261.3609
Charge	0
Count

Stereochemistry	RACEMIC
Additional Stereochemistry	No
Defined Stereocenters	0 / 1
E/Z Centers	0
Optical Activity	( + / - )

Description
Sources: https://www.drugs.com/mtm/phenindamine.html
Curator's Comment: Description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/18907211

Phenindamine (thephorin or 2-methyl-9-phenyl-2,3,4,9-tetrahydro-1-pyridindene) a pyridindene derivative proved to be a potent antihistaminic. Phenindamine was used to treat sneezing; runny nose; itching, watery eyes; hives; rashes; itching; and other symptoms of allergies and the common cold.

CNS Activity

Originator

Approval Year

Targets

Primary Target	Pharmacology	Condition	Potency
Histamine H1 receptor 316 Target ID: CHEMBL231 Sources: https://www.ncbi.nlm.nih.gov/pubmed/7650688 \| https://www.ncbi.nlm.nih.gov/pubmed/18907211	Antagonist 2849

Conditions

Condition	Modality	Targets	Highest Phase	Product
Allergy 44 Sources: https://www.ncbi.nlm.nih.gov/pubmed/18878636 https://www.ncbi.nlm.nih.gov/pubmed/18867853 https://www.ncbi.nlm.nih.gov/pubmed/18879474	Primary		Approved 8583	THEPHORIN Approved Use Phenindamine was used to treat sneezing; runny nose; itching, watery eyes; hives; rashes; itching; and other symptoms of allergies and the common cold. Launch Date 1947

Sourcing

Vendor/Aggregator	ID	URL
001 Chemical	DY573096	https://www.001chemical.com/chem/82-88-2
ABI Chem	AC1L1X1J
Ambinter	Amb17619242	http://www.ambinter.com/reference/17619242
AN PharmaTech	AN-28759
BOC Sciences	1316183
BOC Sciences	569-59-5
BOC Sciences	82-88-2
ChemMol	49419261	http://www.chemmol.com/chemmol/49419261.html
ChemMol	99160490	http://www.chemmol.com/chemmol/99160490.html
Compound Cloud	11290
Compound Cloud	11291
eMolecules	110009458
eMolecules	36759216
eMolecules	48669401
Hangzhou Yuhao Chemical Technology	RT9838
HongKong Chemhere	SCE32562
Molcore	MC573096	https://www.molcore.com/product/82-88-2
MuseChem	R050409
MuseChem	R068189
NCI Plated 2007	91526
NovoSeek	11291
Sigma Aldrich	PH011869
Sigma Aldrich	PH011869\|ALDRICH
THE BioTek	bt-363837	https://www.thebiotek.com/product/others/bt-363837
Toronto Research Chemicals	F594065
Toronto Research Chemicals	H600523
Toronto Research Chemicals	P297000
Yick-Vic Chemicals & Pharmaceuticals (HK) Ltd.	PH-1224
ZINC	ZINC000000968338	http://zinc15.docking.org/substances/ZINC000000968338
ZINC	ZINC000000968340	http://zinc15.docking.org/substances/ZINC000000968340

PubMed

Title	Date	PubMed
The histamine H1-receptor antagonist binding site. A stereoselective pharmacophoric model based upon (semi-)rigid H1-antagonists and including a known interaction site on the receptor.	1995-08-18	7650688
The effects of phenindamine tartrate on sleepiness and psychomotor performance.	1992-12	1360991
Performance enhancement effects of d-amphetamine, methylphenidate, pipradrol and phenindamine in rats.	1976	3816
Histamine and the antihistaminic drugs.	1950-05	15414437
Thephorin in the treatment of disseminated neurodermatitis.	1948-08	18877034
Treatment of allergic and some other dermatoses with thephorin; a preliminary report.	1947-08	20266661

Patents

Sample Use Guides

In Vivo Use Guide

The maximum amount of phenindamine that you should take in 1 day is 75 mg.

Route of Administration: Other

In Vitro Use Guide

Unknown

Substance Class	Chemical Created by `admin` on `Mon Mar 31 17:35:29 GMT 2025` Edited by `admin` on `Mon Mar 31 17:35:29 GMT 2025`
Record UNII	28725X3PV8
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

NOLAHIST

Preferred Name

English

PHENINDAMINE TARTRATE

Official Name

English

PHENINDAMINE BITARTRATE

Common Name

English

PERNOVINE

Common Name

English

1H-INDENO(2,1-C)PYRIDINE, 2,3,4,9-TETRAHYDRO-2-METHYL-9-PHENYL-, (R-(R*,R*))-2,3-DIHYDROXYBUTANEDIOATE (1:1)

Common Name

English

PHENINDAMINE TARTRATE [VANDF]

Common Name

English

PERNOVIN

Brand Name

English

THEPHORIN TARTRATE

Common Name

English

2,3,4,9-TETRAHYDRO-2-METHYL-9-PHENYL-1H-INDENO(2,1-C)PYRIDINE TARTRATE

Systematic Name

English

PHENINDAMINE TARTRATE [USAN]

Common Name

English

2,3,4,9-TETRAHYDRO-2-METHYL-9-PHENYL-1H-INDENO-(2,1-C)PYRIDINE BITARTRATE

Systematic Name

English

NSC-91526

Code

English

1H-INDENO(2,1-C)PYRIDINE, 2,3,4,9-TETRAHYDRO-2-METHYL-9-PHENYL-, (2R,3R)-2,3-DIHYDROXYBUTANEDIOATE (1:1)

Systematic Name

English

PHENINDAMINE TARTRATE [MART.]

Common Name

English

PHENINDAMINE HYDROGEN TARTRATE [MI]

Common Name

English

Phenindamine tartrate [WHO-DD]

Common Name

English

1H-INDENO(2,1-C)PYRIDINE, 2,3,4,9-TETRAHYDRO-2-METHYL-9-PHENYL-, TARTRATE (1:1)

Systematic Name

English

PHENINDAMINE HYDROGEN TARTRATE

Common Name

English

Classification Tree Code System Code

CFR

21 CFR 341.12